Committee Faults FDA for Not Pursuing Heparin Contamination Leads

The Wall Street Journal (4/30, B7, Mundy) reported that, according to an investigation conducted by the House Energy and Commerce Committee, the Food and Drug Administration did not pursue leads which could have fingered those responsible in China for playing a role in the contaminated heparin crisis two years ago. Committee members Rep. Joe Barton (R-TX) and Rep. Mike Burgess (R-TX) sent a letter to the FDA in which they spelled out findings from the investigation and said that it has not pressed the government of China regarding Chinese companies involved.